Systemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology. (Q36490744): Difference between revisions
Jump to navigation
Jump to search
Set a claim value: cites work (P2860): The systemic administration of an anti-miRNA oligonucleotide encapsulated pH-sensitive liposome results in reduced level of hepatic microRNA-122 in mice (Q39025497), разрешение перенаправления / resolving redirect (Q46203193) → The systemic administration of an anti-miRNA oligonucleotide encapsulated pH-sensitive liposome results in reduced level of hepatic microRNA-122 in mice (Q39025497) (подробности / details) |
Added [ast] label: Systemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology. |
||
| label / ast | label / ast | ||
Systemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology. | |||
Revision as of 20:41, 7 January 2020
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Systemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology. |
scientific article |
Statements
1 reference
Systemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology. (English)
1 reference
Dan Shu
1 reference
Hui Li
1 reference
Yi Shu
1 reference
Gaofeng Xiong
1 reference
William E Carson
1 reference
Farzin Haque
1 reference
Ren Xu
1 reference
Peixuan Guo
1 reference
21 September 2015
1 reference
1 reference
9731-9740
1 reference
Identifiers
1 reference
1 reference
1 reference
Sitelinks
Wikipedia(0 entries)
Wikibooks(0 entries)
Wikinews(0 entries)
Wikiquote(0 entries)
Wikisource(0 entries)
Wikiversity(0 entries)
Wikivoyage(0 entries)
Wiktionary(0 entries)
Multilingual sites(0 entries)
